Cargando…

Clinical and Economic Benefits Associated With the Achievement of Both HbA(1c) and LDL Cholesterol Goals in Veterans With Type 2 Diabetes

OBJECTIVE: This study compared the clinical and economic benefits associated with dual-goal achievement, glycated hemoglobin (HbA(1c)) <7% (53 mmol/mol) and LDL cholesterol (LDL-C) <100 mg/dL, with achievement of only the LDL-C goal or only the HbA(1c) goal in veterans with type 2 diabetes mel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Lizheng, Ye, Xin, Lu, Mei, Wu, Eric Q., Sharma, Hari, Thomason, Darren, Fonseca, Vivian A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781519/ https://www.ncbi.nlm.nih.gov/pubmed/23801723 http://dx.doi.org/10.2337/dc13-0149

Ejemplares similares

Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study
por: Shi, Lizheng, et al.
Publicado: (2015)

Empirically Establishing Blood Glucose Targets to Achieve HbA(1c) Goals
por: Wei, Nancy, et al.
Publicado: (2014)

Joint effect of visit-to-visit variability in LDL-cholesterol, HDL-cholesterol and HbA1c on cardiovascular and total mortality in patients with diabetes
por: He, Panpan, et al.
Publicado: (2022)

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
por: Sangsawang, Tamon, et al.
Publicado: (2015)

Four‐year HbA1c and LDL‐cholesterol trajectories among individuals with mental disorders and newly developed type 2 diabetes
por: Kristensen, Frederik P., et al.
Publicado: (2021)

Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
por: Brockmeyer, Maximilian, et al.
Publicado: (2022)

Prevalence of Achievement of A1c, Blood Pressure, and Cholesterol (ABC) Goal in Veterans with Diabetes
por: Vouri, Scott Martin, et al.
Publicado: (2011)

HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
por: Wang, Pin, et al.
Publicado: (2015)

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients
por: Karalis, Dean G., et al.
Publicado: (2012)

Physicians’ behavior following changes in LDL cholesterol target goals
por: Vinker, Shlomo, et al.
Publicado: (2015)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

The Effect of Anemia and the Goal of Optimal HbA1c Control in Diabetes and Non-Diabetes
por: Katwal, Prakash C, et al.
Publicado: (2020)

Glycated Albumin Correlates With Time-in-Range Better Than HbA(1c) or Fructosamine
por: Desouza, Cyrus V, et al.
Publicado: (2023)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Evaluation of LDL goal achievement in statin consumption, south east of Iran
por: Aghasizadeh, Malihe, et al.
Publicado: (2021)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study
por: Peng, Xuejun Victor, et al.
Publicado: (2020)

HbA1c, lipid profiles and risk of incident type 2 Diabetes in United States Veterans
por: Davis, P. Jordan, et al.
Publicado: (2018)

Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study
por: Tan, Joshua Kuan, et al.
Publicado: (2023)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
por: Clem, James R, et al.
Publicado: (2009)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Individualized HbA(1c) Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey
por: Lautsch, Dominik, et al.
Publicado: (2021)

Using Wearable Sensors to Measure Goal Achievement in Older Veterans with Dementia
por: Freytag, Jennifer, et al.
Publicado: (2022)

HbA1c, blood pressure, and cholesterol control in adults with diabetes: A report card for Kuwait
por: Alkandari, Abdullah, et al.
Publicado: (2022)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?
por: Ibn Elhadj, Zied, et al.
Publicado: (2022)

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%
por: Owens, David R., et al.
Publicado: (2019)

Portrait for Type 2 Diabetes with Goal-Achieved HbA1c Using Digital Diabetes Care Model: A Real-World 12-Month Study from China
por: Li, Mingzhen, et al.
Publicado: (2023)

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
por: Ali, Amar, et al.
Publicado: (2019)

The influence of shorter red blood cell lifespan on the rate of HbA1c target achieved in type 2 diabetes patients with a HbA1c detection value lower than 7%
por: Wang, Junmei, et al.
Publicado: (2022)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c
por: Gallwitz, Baptist, et al.
Publicado: (2017)

Hb H Interference on Measurement Of HbA1c With Ion-Exchange HPLC
por: Agilli, Mehmet, et al.
Publicado: (2013)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

HbA1c as a shared treatment goal in type 2 diabetes? A secondary analysis of the DEBATE trial
por: Santos, Sara, et al.
Publicado: (2023)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)

In-House Algorithm for Reporting Discrepant HbA1c Result and Troubleshooting a Case of False Low HbA1c
por: Pant, Vivek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tp1pg2rpt2va2k0lmiqb4jboqm